Buying more every time it comes under $0.40 myself. Striate all but sealed this companies continued future. Alas its typical for Australian finance, for a small company's partnership with a huge Pharma like Henry Schein go relatively unnoticed. We are all mostly on for other applications of the CelGro technology, or ATI potential per this thread. That the company is still trading at the same levels to pre-announcement is absurd.
Made some nice money on some derivatives and a couple of other Aus pharma's that got results/news. All slowly going back in here.
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients, page-62
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $139.0M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 66.5¢ | 64.5¢ | $276.6K | 421.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25500 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |